We aimed to develop dose–response relationships for heart failure (HF) following radiation and anthracyclines in breast cancer treatment, and to assess HF associations with trastuzumab and endocrine therapies.
Methods and Results:Expand abstract
A case–control study was performed within a cohort of breast cancer survivors treated during 1980–2009. Cases (n = 102) had HF as first cardiovascular diagnosis and were matched 1:3 on age an...
- Publication status:
- Peer review status:
- Peer reviewed
- Wiley Publisher's website
- European Journal of Heart Failure Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Source identifiers:
- Local pid:
- Copyright holder:
- Boekel et al.
- Rights statement:
- © 2019 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Heart failure after treatment for breast cancer
If you are the owner of this record, you can report an update to it here: Report update to this record